Will Chart Analysts Notice Bad Omen on Icahn Enterprises’s Chart

If history is any guide, there may be trouble ahead for shares of Icahn Enterprises (NASDAQ:IEP). A so-called…

If history is any guide, there may be trouble ahead for shares of Icahn Enterprises (NASDAQ:IEP). A so-called “death cross” has formed on its chart and, not surprisingly, this could be bearish for the stock.

What To Know: Many traders use moving average crossover systems to make their decisions.

When a shorter-term average price crosses above a longer-term average price, it could mean the stock is trending higher. If the short-term average price crosses below the long-term average price, it means the trend is lower.

Why It’s Important: The 50-day and the 200-day simple moving averages are commonly used.

The death cross occurs when the 50-day moves below the 200-day. This could mean the long-term trend is changing.

That just happened with Icahn Enterprises, which is trading around $51.29 at publication time.

signals

Remember: Seasoned investors don’t blindly trade Death Crosses.

Instead, they use it as a signal to start looking for short positions based on other factors, like price levels and company fundamentals & events.

For seasoned investors, this is just a sign that it might be time to start considering possible short positions.

With that in mind, take a look at Icahn Enterprises’s past and upcoming earnings expectations:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate 0.15 0.22 0.07 0.13
EPS Actual -0.74 -0.37 -0.41 1.06
Revenue Estimate 2.67B 2.77B 2.65B 2.28B
Revenue Actual 3.10B 3.40B 3.50B 2.97B

Do you use the Death Cross signal in your trading or investing? Share this article with a friend if you found it helpful!

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Heart Devices Focused Silk Road Medical Stock Gets an Upgrade – Analyst Says New CEO’s Initiatives Sets Stage For ‘Back On Track’

Stifel's upgraded outlook on Silk Road Medical as CEO Chas McKhann addresses concerns, unveils a compelling vision, and outlines strategic initiatives. Analysts upgrade to Buy with $20 price target, citing confidence in TCAR technology and long-term growth under McKhann's leadership.

SILK

Read More

Lind Partners Statement On FingerMotion, Inc.; Says ‘Anonymous Individuals Alleging That Lind Partners Has Taken Naked Short Positions In FingerMotion Are Disseminating False Information’

Over the course of the last 15 months, Lind Partners has been the target of a small group of nefarious individuals spreading misinformation about our position with FingerMotion, Inc. (NASDAQ:FNGR). While our general

FNGR